Novadip Biosciences

Rue Granbonpré 11
1435 MONT-SAINT-GUIBERT
Belgium

[email protected] +32 10 77 92 20 www.novadip.com

Type
- Company
Application domains
- Biopharma
Core business
- R&D
Technology
- Cell therapy
- Regenerative medicine
Therapeutic area
- Orthopaedics

Novadip develops regenerative therapies for critical bone defects, utilizing adipose-derived stem cells to accelerate healing in conditions like bone non-union and spinal fusion.

Related projects

Projects

Revive

Theramir

Solit

All member's projects

Related news

News

Novadip recruits first pediatric patients in pivotal phase 3 trial of tissue regenerative treatment NVD003 in congenital pseudoarthrosis of the tibia

Novadip-courtesy-of-Cliniques-universitaires-Saint-Luc-avec-lautorisation-des-Cliniques-universitaires-Saint-Luc

Novadip and Cliniques universitaires Saint-Luc report positive results for compassionate use of NVD003 on four pediatric patients

Novadip-NVD003-shipped-ready-for-the-implantation-to-the-patient

Novadip receives RMAT designation for NVD003, its regenerative treatment for congenital pseudarthosis of the tibia

All member's news